top of page

Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

About the study

NCT Trial Number

NCT03554174

The drug being studied

Psilocybin

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Yale University|Heffter Research Institute

noun_date_3237048.png

Trial Start Date

Jun-18

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

Yes

A study to explore changes in brain signalling after psilocybin in patients with depression.

Eyes Graffiti

Locations

United States, Connecticut
VA Connecticut Healthcare System, West Haven Campus Recruiting
West Haven, Connecticut, United States, 06516

Contact: Surbhi Pathania, MBBS
(203) 932-5711 ext 4650
surbhi.pathania@yale.edu

Contact: Christina Luddy, BS
(203) 932-5711 ext 4549
christina.luddy@yale.edu

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page